Monsanto Co is negotiating with Bayer AG and other companies in relation to alternative strategic options, a month after he rejected a takeover offer by German company for $62 billion, according to the American seed producer on Wednesday.

Options include Monsanto cooperation with other companies and business in the sector not covered by Bayer. The potential agreement may include BASF and any of the company sold in the merger of Dow/DuPont, according to analysts.

Monsanto, which also reported Wednesday on weaker than anticipated sales for the sixth quarter in a row, turned to Bayer concerning the possibility of purchasing her research of the agricultural division, as reported by Reuters in March.

Monsanto remains the preferred partner in this industry, and the company will continue to actively explore these opportunities.

Monsanto reported that there was no official change proposals Bayer, but negotiations continued over the last few weeks.

Representative Bayer announced that the company has no comment.

The industry of seeds and agrochemicals, a long time were in the power of the six major companies got a jolt from a few large deals in the past year because of low grain prices and savings of farmers has put pressure on revenues. Syngenta agreed in February to be acquired by ChemChina for $43 billion, while Dow Chemical and DuPont announced Megaline for $130 billion last year.

Bayer, however, has no plans to raise its offer, not having received the confidential information from Monsanto, the sources said.

Bayer has planned to issue new shares of approximately $15.4 billion, to help Fund the proposed agreement.

Weak income Monsanto can increase the possibility of merger/acquisition for the company, according to Bernstein analysts.

Monsanto reported that net income fell by more than 37% to $717 million, or 1.63 of$ per share, in the third quarter ended may 31.

Universal global glut of glyphosate, the active ingredient in the herbicide Roundup, Monsanto, and delay issuance of permits for import of GM soy by Monsanto next-generation the European Union has reduced the profit during the quarter, the company said.

Earnings per share amounted to 2,17$ from continuing operations, which is significantly below the average analysts ' forecast of 2.40$.

Net sales decreased by 8.5% to $4,19 billion, reaching forecasts of $4.49 billion

Source: Thomson Reuters